CCA
CELG

Catalyst Capital Advisors’s Celgene Corp CELG Stock Holding History

Catalyst Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-702
Closed -$70K – 468
2019
Q3 		$70K Buy
702
+271
+63% +$25.8K ﹤0.01% 247
2019
Q2 		$40K Buy
+431
New +$40.9K ﹤0.01% 238
2018
Q3 		– Sell
-8,700
Closed -$691K – 577
2018
Q2 		$691K Buy
8,700
+3,350
+63% +$278K 0.02% 181
2018
Q1 		$477K Buy
+5,350
New +$514K 0.02% 211
2015
Q3 		– Sell
-47,000
Closed -$5.44M – 685
2015
Q2 		$5.44M Hold
47,000
– – 0.63% 67
2015
Q1 		$5.42M Buy
47,000
+23,000
+96% +$2.75M 0.62% 68
2014
Q4 		$2.69M Buy
24,000
+4,300
+22% +$453K 0.32% 83
2014
Q3 		$1.87M Buy
+19,700
New +$1.78M 0.24% 95
2013
Q3 		– Sell
-2,414
Closed -$141K – 351
2013
Q2 		$141K Buy
+2,414
New +$145K 0.11% 199

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Catalyst Capital Advisors's CELG Position: Q4 2019 in Review

Catalyst Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 702 shares — an estimated $70K sold.

Catalyst Capital Advisors first reported a position in CELG in Q2 2013 and held it in 9 quarters. The position peaked at $5.44M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Catalyst Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Catalyst Capital Advisors sold 702 Celgene Corp shares in Q4 2019, an estimated $70K.
  • Catalyst Capital Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 9 quarters.
  • Catalyst Capital Advisors's Celgene Corp position peaked at $5.44M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Catalyst Capital Advisors's 13F filing for Q4 2019, filed 6 Feb 2020.